SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-063885
Filing Date
2018-12-21
Accepted
2018-12-21 16:03:45
Documents
2
Period of Report
2018-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
2 POA DOCUMENT poa.txt EX-24.3_822414 3037
  Complete submission text file 0001209191-18-063885.txt   5998
Mailing Address C/O COLLAGENEX PHARMACEUTICALS, INC. 41 UNIVERSITY DRIVE NEWTOWN PA 18940
Business Address
Powell Andrew Kenneth William (Reporting) CIK: 0001304113 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38756 | Film No.: 181249523

Mailing Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037 858-750-4715
Synthorx, Inc. (Issuer) CIK: 0001609727 (see all company filings)

IRS No.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences